Patents Assigned to Genesis Systems Corporation
  • Patent number: 5140021
    Abstract: A pharmaceutical composition suitable for oral administration comprises micronized progesterone in an oil vehicle which is high in glycerides of polyunsaturated fatty acids. Micronized progesterone particles suspended in such an oil vehicle are absorbed more readily into the bloodstream and achieve high progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of premenstrual syndrome.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: August 18, 1992
    Assignee: Genesis Systems Corporation
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Philip G. Meyers
  • Patent number: 5093265
    Abstract: Premenstrual syndrome (PMS) and other conditions may be diagnosed according to the invention by measuring the level of luteinizing hormone antibodies in the system of a woman subject. A low level of such antibodies as compared to levels measured for non-PMS women indicates that the patient suffers from PMS. A patient identified by this method is then treated as needed, such as by oral administration of progesterone, to alleviate the symptoms of the condition.
    Type: Grant
    Filed: December 16, 1987
    Date of Patent: March 3, 1992
    Assignee: Genesis Systems Corporation
    Inventors: Edward M. Portman, Austin L. Shug